Thorne Research launches NiaCel
date:Apr 08, 2014
+ in cells and tissue. Studies have demonstrated that increasing the levels of NAD+ can support healthy aging by stimulating mitochondrial energy production, as well as by activating sirtuin function.

We are very excited to offer NIAGEN nicotinamide riboside to our practitioner network through this new, exclusive product launch, said Paul Jacobson, CEO of Thorne Research. NiaCel provides practitioners with a powerful new solution to promote healthy aging in patients. NIAGEN is one of the most i
2/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/15 20:40